Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy
- 13 November 1997
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 96 (5) , 354-361
- https://doi.org/10.1111/j.1600-0447.1997.tb09929.x
Abstract
In this study, follow-up results of cognitive-behaviour therapy and of a combination of cognitive-behaviour therapy with a serotonergic antidepressant were determined. The study also examined factors that can predict this treatment effect, both in the long term and in the short term. In addition, it investigated whether differential prediction is possible for cognitive-behaviour therapy vs. a combination of cognitive-behaviour therapy with a serotenergic antidepressant. A total of 99 patients were included in the study. Treatment lasted 16 weeks, and a naturalistic follow-up measurement was made 6 months later. Of the 70 patients who completed the treatment, follow-up information was available for 61 subjects. Significant time effects were found on all outcome measures at both post-treatment measurement and follow-up. No differences in efficacy were found between the treatment conditions. Effectiveness at post-treatment measurement appears to predict success at follow-up. However, 17 of the 45 non-responders at the post-treatment measurement had become responders by the follow-up. The severity of symptoms, motivation for treatment and the dimensional score on the PDQ-R for cluster A personality disorder appear to predict treatment outcome. No predictors were found that related specifically to cognitive-behaviour therapy or combined treatment. These results indicate that the effectiveness of cognitive-behaviour therapy or a combination of cognitive-behaviour therapy and fluvoxamine at the post-treatment measurement is maintained at follow-up. However, non-response at post-treatment does not always imply non-response at follow-up. Patients with more severe symptoms need a longer period of therapy to become responders. Although predictors for treatment success were found, no evidence was found to determine the choice of one of the treatment modalities.Keywords
This publication has 24 references indexed in Scilit:
- Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorderPublished by Elsevier ,2000
- Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorderClinical Psychology Review, 1995
- Reliability and validity of the Yale-Brown Obsessive-Compulsive ScaleBehaviour Research and Therapy, 1995
- Prognostic factors in the behavioral treatment of panic disorder with and without agoraphobiaBehavior Therapy, 1994
- Predictors of Treatment Response in Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1994
- A meta-analysis on the treatment of obsessive compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapyClinical Psychology Review, 1994
- Predictive Factors in the Treatment of Obsessive-Compulsive Disorders with Fluvoxamine and/or Behaviour TherapyBehavioural Psychotherapy, 1993
- Personality traits and disorders in obsessive-compulsivesJournal of Anxiety Disorders, 1990
- Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significanceBehavior Therapy, 1984
- Treatment of Chronic Obsessive-Compulsive Neurosis by in-vivo ExposureThe British Journal of Psychiatry, 1975